Anna Karin Gertrud Linnea Belfrage
10Patents
3h-index
33Co-inventors
56Inventor score
Filing activity: Jul 28, 2006 → Mar 9, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8349869B2 | Macrocylic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 12 | Active |
| US7659245B2 | Macrocylic inhibitors of hepatitis C virus | Chemistry; Metallurgy | 12 | Active |
| US8937080B2 | Pyrimidine substituted macrocyclic HCV inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US8741926B2 | Macrocyclic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 1 | Active |
| US8754106B2 | Macrocyclic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US8383584B2 | HCV inhibiting macrocyclic phenylcarbamates | Chemistry; Metallurgy | 0 | Active |
| US9856265B2 | Macrocyclic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US8853281B2 | Cysteine protease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9353103B2 | Macrocyclic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US9623022B2 | Macrocyclic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.